Double valve replacement in a patient with anticardiolipin antibody syndrome

Perfusion

Volumn 14, Issue 5, 1999, Pages 397-401

  Myers, Gerard J ^a,b   Hirsch, Gregory M ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; ANTIPHOSPHOLIPID SYNDROME; AORTA VALVE; ARTICLE; CARDIOPULMONARY BYPASS; CASE REPORT; FEMALE; HEART VALVE REPLACEMENT; HUMAN; MITRAL VALVE; PATIENT MONITORING; PRIORITY JOURNAL;

EID: 0032858241     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765919901400512     Document Type: Article

References (17)

1. Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hematol 1972; 1: 75-95.
2. Schlieder MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509.
3. Asherson RA, Harris EN. Anticardiolipin antibodies in the detection of autoimmune disorders. Immunol Microbiol 1987; 8: 73.
4. Hughes GV, Harris EN, Gharavi, AE. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-89.
5. Lechner K, Pabinger-Fasching I. Lupus anticoagulants and thrombosis. Haemostasis 1985; 15: 254-62.
6. Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin M coagulation inhibitor with phospholipid specificity. J Clin Invest 1980; 66: 397-405.
7. Harris EN, Gharavi AE, Boey ML et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; 2: 1211-14.
8. Triplett DA, Brandt JT, Musgrave, KA, Orr CA. The relationship between lupus anticoagulants and antibodies to phospholipid. J Am Med Assoc 1988; 259: 550-54.
9. Ciocca RG, Choi J, Graham AM. Antiphospholipid antibodies lead to increased risk in cardiovascular surgery Am J Surg 1995; 170: 198-200.
10. Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AF, Hughes GRV. Thrombosis, recurrent fetal loss, and thrombocytopenia. Arch Intern Med 1986; 146: 2153-56.
11. Finazzi G, Brancaccio V, Moia M et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four year prospective study from the Italian Registry. Am J Med 1996; 100: 530-36.
12. Morton KE, Gavaghan TP, Krilis SA et al. Coronary artery bypass graft failure ... an autoimmune phenomenon? Lancet 1986; 13: 1353-57.
13. Gastineau DA, Kazmier FJ, Nichols WL, Bowie EJ. Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985; 19: 265-75.
14. Gladman DD, Urovitz MB, Tozman EC, Glynn MF. Hemostatic abnormalities in systemic lupus erythematosus. Q J Med 1983; 52(207): 424-33.
15. Brandt J, Triplett D, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
16. Khamashta M, Cuadrado M, Mujic F, Taub NA, Hunt BJ, Hughes GR. The management of thrombosis in the antiphospholopid antibody syndrome. N Engl J Med 1995; 332: 993-97.
17. Galli M, Finazzi G, Bevers E, Barbin T. Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodies. Blood 1995; July: 617-23.